Literature DB >> 25125050

Amyloid-β(1-42) protofibrils stimulate a quantum of secreted IL-1β despite significant intracellular IL-1β accumulation in microglia.

Shana E Terrill-Usery1, Michael J Mohan1, Michael R Nichols2.   

Abstract

Neuroinflammation is a characteristic feature of the Alzheimer's disease (AD) brain. Significant inflammatory markers such as activated microglia and cytokines can be found surrounding the extracellular senile plaques predominantly composed of amyloid-β protein (Aβ). Several innate immune pathways, including Toll-like receptors (TLRs) and the NLRP3 inflammasome, have been implicated in AD inflammation. Aβ plays a primary role in activating these pathways which likely contributes to the progressive neurodegeneration in AD. In order to better understand the complexities of this interaction we investigated the inflammatory response of primary microglia to Aβ(1-42) protofibrils. Aβ(1-42) protofibrils triggered a time- and MyD88-dependent process that produced tumor necrosis factor alpha (TNFα) and interleukin-1β (IL-1β) mRNA, and intracellular pro and mature forms of IL-1β protein. The accumulation of both IL-1β forms indicated that Aβ(1-42) protofibrils were able to prime and activate the NLRP3 inflammasome. Surprisingly, Aβ-induced accumulation of intracellular mature IL-1β did not translate into greater IL-1β secretion. Instead, we found that Aβ elicited a quantized burst of secreted IL-1β and this process occurred even prior to Aβ priming of the microglia suggesting a basal level of either pro or mature IL-1β in the cultured primary microglia. The IL-1β secretion burst was rapid but not sustained, yet could be re-evoked with additional Aβ stimulation. The findings from this study demonstrated multiple sites of IL-1β regulation by Aβ(1-42) protofibrils including TLR/MyD88-mediated priming, NLRP3 inflammasome activation, and modulation of the IL-1β secretory process. These results underscore the wide-ranging effects of Aβ on the innate immune response.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Amyloid-beta protein; Interleukin 1-beta; Microglia; NLRP3 inflammasome; Protofibril; Toll-like receptors

Year:  2014        PMID: 25125050      PMCID: PMC4188733          DOI: 10.1016/j.bbadis.2014.08.001

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  45 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  Inflammation takes on Alzheimer disease.

Authors:  Todd E Golde
Journal:  Nat Med       Date:  2002-09       Impact factor: 53.440

3.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

Authors:  D M Walsh; A Lomakin; G B Benedek; M M Condron; D B Teplow
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

4.  The activation of P2X7 receptor induces cathepsin D-dependent production of a 20-kDa form of IL-1β under acidic extracellular pH in LPS-primed microglial cells.

Authors:  Takato Takenouchi; Yoshifumi Iwamaru; Shuei Sugama; Mitsutoshi Tsukimoto; Masayo Fujita; Akio Sekigawa; Kazunari Sekiyama; Mitsuru Sato; Shuji Kojima; Bruno Conti; Makoto Hashimoto; Hiroshi Kitani
Journal:  J Neurochem       Date:  2011-03-28       Impact factor: 5.372

5.  Amyloid beta protein (A beta) in Alzheimer's disease brain. Biochemical and immunocytochemical analysis with antibodies specific for forms ending at A beta 40 or A beta 42(43).

Authors:  S A Gravina; L Ho; C B Eckman; K E Long; L Otvos; L H Younkin; N Suzuki; S G Younkin
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

6.  CD14 and toll-like receptors 2 and 4 are required for fibrillar A{beta}-stimulated microglial activation.

Authors:  Erin G Reed-Geaghan; Julie C Savage; Amy G Hise; Gary E Landreth
Journal:  J Neurosci       Date:  2009-09-23       Impact factor: 6.167

7.  Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.

Authors:  Malabendu Jana; Carlos A Palencia; Kalipada Pahan
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

8.  Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer's disease.

Authors:  T Kawarabayashi; L H Younkin; T C Saido; M Shoji; K H Ashe; S G Younkin
Journal:  J Neurosci       Date:  2001-01-15       Impact factor: 6.167

9.  Effects of low dose GM-CSF on microglial inflammatory profiles to diverse pathogen-associated molecular patterns (PAMPs).

Authors:  Nilufer Esen; Tammy Kielian
Journal:  J Neuroinflammation       Date:  2007-03-20       Impact factor: 8.322

Review 10.  Understanding the mechanism of IL-1β secretion.

Authors:  Gloria Lopez-Castejon; David Brough
Journal:  Cytokine Growth Factor Rev       Date:  2011-10-22       Impact factor: 7.638

View more
  17 in total

1.  CD47 does not mediate amyloid-β(1-42) protofibril-stimulated microglial cytokine release.

Authors:  Sanjib Karki; Michael R Nichols
Journal:  Biochem Biophys Res Commun       Date:  2014-10-22       Impact factor: 3.575

2.  Iron potentiates microglial interleukin-1β secretion induced by amyloid-β.

Authors:  Israel C Nnah; Chih-Hao Lee; Marianne Wessling-Resnick
Journal:  J Neurochem       Date:  2020-01-21       Impact factor: 5.372

3.  [Protective effect of butylphthalide in a cell model of Alzheimer's disease induced by Aβ25-35 in Neuro 2a cells].

Authors:  Jing-Wen Xie; Yan Zhao; Xia-Lu Feng; Fang-Bo Lin; Jing Luo; Xin Liu; De-Ren Hou
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2017-09-20

4.  Amyloid-β42 protofibrils are internalized by microglia more extensively than monomers.

Authors:  Lisa K Gouwens; Nyasha J Makoni; Victoria A Rogers; Michael R Nichols
Journal:  Brain Res       Date:  2016-08-13       Impact factor: 3.252

5.  Development of a Simple and Effective Lipid-A Antagonist Based on Computational Prediction.

Authors:  Olivia Slater; Kapur B Dhami; Ganesh Shrestha; Maria Kontoyianni; Michael R Nichols; Alexei V Demchenko
Journal:  ACS Infect Dis       Date:  2022-05-25       Impact factor: 5.578

Review 6.  Inflammatory mechanisms in neurodegeneration.

Authors:  Michael R Nichols; Marie-Kim St-Pierre; Ann-Christin Wendeln; Nyasha J Makoni; Lisa K Gouwens; Evan C Garrad; Mona Sohrabi; Jonas J Neher; Marie-Eve Tremblay; Colin K Combs
Journal:  J Neurochem       Date:  2019-03-27       Impact factor: 5.372

Review 7.  Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer's disease.

Authors:  Tiantian Guo; Denghong Zhang; Yuzhe Zeng; Timothy Y Huang; Huaxi Xu; Yingjun Zhao
Journal:  Mol Neurodegener       Date:  2020-07-16       Impact factor: 14.195

8.  The conformational epitope for a new Aβ42 protofibril-selective antibody partially overlaps with the peptide N-terminal region.

Authors:  Benjamin A Colvin; Victoria A Rogers; Joshua A Kulas; Elizabeth A Ridgway; Fatima S Amtashar; Colin K Combs; Michael R Nichols
Journal:  J Neurochem       Date:  2017-11-22       Impact factor: 5.372

Review 9.  Cell Type Specific Expression of Toll-Like Receptors in Human Brains and Implications in Alzheimer's Disease.

Authors:  Henriette R Frederiksen; Henriette Haukedal; Kristine Freude
Journal:  Biomed Res Int       Date:  2019-07-18       Impact factor: 3.411

10.  Network Analysis of a Comprehensive Knowledge Repository Reveals a Dual Role for Ceramide in Alzheimer's Disease.

Authors:  Satoshi Mizuno; Soichi Ogishima; Kazuyuki Kitatani; Masataka Kikuchi; Hiroshi Tanaka; Nobuo Yaegashi; Jun Nakaya
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.